Article info

Download PDFPDF

Original research
Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells

Authors

  1. Correspondence to Dr Scott J Roberts; scott.roberts{at}ucl.ac.uk
View Full Text

Citation

Shah M, Maroof A, Gikas P, et al
Dual neutralisation of IL-17F and IL-17A with bimekizumab blocks inflammation-driven osteogenic differentiation of human periosteal cells

Publication history

  • Received May 5, 2020
  • Revision received June 25, 2020
  • Accepted June 25, 2020
  • First published July 28, 2020.
Online issue publication 
July 28, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.